The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Medicomp sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Medicomp operates as a medical device company that offers cardiology care products. The company develops, manufactures and markets ambulatory heart-monitoring systems and improves existing technologies and creates new applications. Medicomp offers products such as wireless, mobile cardiac telemetry, event monitors, holter monitors and epicardia holter systems. The company’s services comprise wireless event monitoring, TTM event, holter, AF burden, clinical trial monitoring, mobile cardiac telemetry and arrhythmia access. Medicomp also offers ECG clinical trial monitoring and insurance services. The company serves the cardiac telemedicine industry across the US. Medicomp is headquartered in Melbourne, Florida, the US.
The key metrics of Medicomp related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Medicomp is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Medicomp.
For a detailed understanding of the performance of Medicomp, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
